PharmiWeb.com - Global Pharma News & Resources

Healthcare - Press Releases

Date Title Company
08-Jun-2020 How You Can Use Video Conferencing Platforms to Improve Your Health Husky Marketing
08-Jun-2020 AI to deliver next evolution of drug manufacturing and supply chain efficiency Pharmapack
06-Jun-2020 AI-remote health monitoring technology offered for free to care homes during Covid-19 Vtuls
06-Jun-2020 Pharmacy Automation Market: Increasing Awareness Among Pharmacists Markets and Markets Research Pvt. Ltd.
05-Jun-2020 Calliditas Therapeutics prices its initial public offering on The Nasdaq Global Select Market in the United States Calliditas Therapeutics AB
05-Jun-2020 AstraZeneca presents new data across continuum of care from its broad renal portfolio at ERA-EDTA 2020 Virtual Congress AstraZeneca
05-Jun-2020 UCB Shares Breadth of Innovative New Data from Rheumatology Portfolio for EULAR 2020 E-Congress UCB
04-Jun-2020 Lupin signs distribution agreements in key EU territories for orphan drug NaMuscla® Lupin
04-Jun-2020 AMRYT AND SWIXX SIGN DISTRIBUTION DEAL FOR MYALEPTA ACROSS 17 JURISDICTIONS IN CENTRAL AND EASTERN EUROPE (“CEE”) AMRYT PHARMA PLC
04-Jun-2020 Santhera Receives Financing Commitment of up to CHF 20 Million from Fund Managed by Highbridge Capital Management Santhera Pharmaceuticals
04-Jun-2020 Chi-Med Announces the Continuation of Phase III FRUTIGA Study of Fruquintinib in Second-Line Gastric Cancer in China Following a Planned Interim Data Review Chi-Med
04-Jun-2020 Smarter and faster FEP calculations enable more cost-efficient drug research Cresset
04-Jun-2020 Celltrion Healthcare showcases positive 1-year data and budget impact analysis for novel subcutaneous formulation of infliximab in patients with rheumatoid arthritis at the European E-Congress of Rheumatology 2020 Celltrion
04-Jun-2020 AlzeCure announces positive data from clinical study with ACD856 About AlzeCure® Pharma
04-Jun-2020 UNLOCKING THE POWER OF THE IMMUNE SYSTEM: UNCOVERING THE IMMUNOGENIC EFFECT OF CHEMOTHERAPY Cancer Research UK
04-Jun-2020 Stilla Technologies presents a novel approach for COVID-19 testing combining group testing with digital PCR and publishes the largest comparative study to date for group testing of SARS-CoV-2 Stilla Technologies
04-Jun-2020 ENHERTU® (Trastuzumab Deruxtecan) Achieved a Tumour Response Rate of 45.3% (95% CI, 70.2%-91.9%) in Patients with HER2 Positive Metastatic Colorectal Cancer in Phase 2 DESTINY-CRC01 Trial1 AstraZeneca
04-Jun-2020 NHS App Integrates eConsult for Online Consultations NHS
04-Jun-2020 VIVEbiotech collaborates with Xyphos Biosciences for clinical development support of convertibleCAR-T(TM) cell therapy Astellas Pharma Inc
04-Jun-2020 AbbVie at EULAR | New Long-term Data from RINVOQ™ (upadacitinib, 15 mg) Phase 3 Studies in Rheumatoid Arthritis AbbVie